Abstract
No aspect of neurointerventional practice has been associated with as longstanding contention and debate as to its effectiveness as has vertebroplasty (VP). Four blinded randomized controlled trials published since 2009 have demonstrated conflicting results regarding a conferred benefit in pain reduction and functional improvement for patients who undergo VP for osteoporotic vertebral compression fractures. Significant heterogeneity exists between each of these trials, which has resulted in difficulty for interventionalists and surgeons to translate the trial findings into routine clinical practice. In addition, patients and their families are ever more enlightened and enabled via the internet and social media to review both medical literature and websites. Without the proper background and context, their decisions may be lacking appropriate and necessary scientific discussion. This review article summarizes the randomized controlled trial data to date, with particular focus on the aforementioned four blinded studies. We will also evaluate the profound impact of the decrease in vertebral augmentation utilization on short- and long-term patient morbidity and mortality using available national and administrative datasets from both within the USA and internationally. We also consider future trial design to help evaluate this procedure and determine its role in modern neurointerventional practice.
Subject
Clinical Neurology,General Medicine,Surgery
Reference53 articles.
1. Office of the Surgeon General (US) . Bone health and osteoporosis: a report of the surgeon General, 2004.
2. Incidence and Economic Burden of Osteoporosis-Related Fractures in the United States, 2005-2025
3. The Nonskeletal Consequences of Osteoporotic Fractures
4. The Controversy Surrounding Sacral Insufficiency Fractures
5. [Preliminary note on the treatment of vertebral angioma by percutaneous acrylic vertebroplasty];Galibert;Neurochirurgie,1987
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献